INVO Fertility Gains Full Control of Alabama Clinic
I'm LongbridgeAI, I can summarize articles.INVO Fertility acquired full control of its Alabama joint venture for $175,001 and resolved Nasdaq compliance issues by filing late reports. While the acquisition consolidates operations, analyst sentiment remains cautious due to weak financial performance, cash burn, and bearish technicals, with a 'Buy' rating at $4.00 target.
INVO Fertility ( (IVF) ) just unveiled an update.
On June 23, 2026, INVO Fertility’s subsidiary INVO Centers acquired 100% of the membership interests in HRCFG, its joint venture partner in the Birmingham, Alabama fertility clinic, for a total consideration of $175,001 structured with minimal upfront cash and deferred payments tied partly to HRCFG’s free cash flow. The deal transfers all business-related assets and intellectual property to HRCFG, provides for up to sixteen months of transition and support services from the sellers, and brings the Alabama joint venture, one of INVO’s four existing clinics, fully into the company’s consolidated financial statements.
Separately, the company resolved prior Nasdaq compliance issues after late filings of its 2025 Form 10-K and first-quarter 2026 Form 10-Q, with Nasdaq staff confirming on June 23, 2026 that INVO had regained compliance with timely filing requirements following submission of the outstanding quarterly report. The closure of the listing matter removes an overhang regarding the company’s exchange status and may reduce regulatory uncertainty for investors and other stakeholders.
The most recent analyst rating on (IVF) stock is a Buy
with a $4.00 price target.
To see the full list of analyst forecasts on INVO Fertility stock,
see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Neutral.
The score is held down primarily by weak financial performance—large losses and persistent cash burn—despite strong revenue growth and improved gross margins. Technicals also remain bearish with the stock trading below major moving averages. Valuation is difficult to support given negative earnings, and the Nasdaq filing/compliance notice adds an additional risk overhang.
To see Spark’s full report on IVF stock,
click here.
More about INVO Fertility
INVO Fertility Inc. operates in the fertility and reproductive health industry, providing assisted reproductive services through a network of clinics, including joint ventures such as the Birmingham, Alabama facility. The company’s business model centers on operating and expanding fertility clinics, with a focus on integrating partner-operated centers into its consolidated operations.
Average Trading Volume: 296,801
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.45M